Resmed in den Nachrichten
Medizinprodukte für chronische Krankheiten
Tamtam hat 20 aktuelle Artikel über Resmed gefunden.
- ResMed CEO Michael J. Farrell Vests 48,136 Performance-Based Shares in November 2026
- Form 4 RESMED INC For: Nov 19 Filed by: Drexler Karen
- Form 4 RESMED INC For: Nov 19 Filed by: De Witte Jan
- Is This the Right Time to Hold Resmed Stock in Your Portfolio?
- Form 4 RESMED INC For: Nov 19 Filed by: Leong Justin
- How Resmed Inc. (RMD) Affects Rotational Strategy Timing
- ResMed director Ronald Taylor retires from board
- Three years of results could put ResMed (RMD) executives at twice their FY2027 stock award targets.
- Is At Home Sleep Testing Altering The Investment Case For ResMed (RMD)?
- ResMed Board Reduced to Ten Directors After Ronald Taylor Retirement at November 2026 Annual Meeting
- Why Are ResMed (ASX:RMD), Commonwealth Bank and BHP Blue Chips in Focus?
- FDA puts gastric implants on device shortages list, adds Resmed product discontinuation
- ResMed director Jan De Witte sells $101,673 of common stock By Investing.com
- ResMed (RMD) director plans to sell 429 shares acquired through stock vesting.
- ResMed Inc. (ASX:RMD): How Do FY27 First-Quarter Results Compare With Its Annual Outlook?
- ResMed (ASX:RMD) vs Pro Medicus (ASX:PME): Health Rally Twist
- ResMed (ASX:RMD) Margin Expansion Puts the Spotlight Back on Profit
- Resmed (ASX:RMD): What Do September-Quarter Earnings and FY27 Guidance Show?
- ResMed Share Price: A$35.20, Up 0.69% Nov 16
- ResMed (RMD), Why Is The Sleep Health Leader Back In Focus?
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Resmed?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden